Absolute Quantification of Toxicological Biomarkers via Mass Spectrometry
Thomas Y K Lau1, Ben C Collins2, Peter Stone3
1Pfizer Inc., 1 Burtt Road, Andover, MA, 01810, USA. thomas.lau@pfizer.com.
Abstract:
With the advent of "-omics" technologies there has been an explosion of data generation in the field of toxicology, as well as many others. As new candidate biomarkers of toxicity are being regularly discovered, the next challenge is to validate these observations in a targeted manner. Traditionally, these validation experiments have been conducted using antibody-based technologies such as Western blotting, ELISA, and immunohistochemistry. However, this often produces a significant bottleneck as the time, cost, and development of successful antibodies are often far outpaced by the generation of targets of interest. In response to this, there recently have been several developments in the use of triple quadrupole (QQQ) mass spectrometry (MS) as a platform to provide quantification of proteins. This technology does not require antibodies; it is typically less expensive and quicker to develop assays and has the opportunity for more accessible multiplexing. The speed of these experiments combined with their flexibility and ability to multiplex assays makes the technique a valuable strategy to validate biomarker discovery.
Insights
Triple quadrupole mass spectrometry (QQQ-MS) offers a faster, more cost-effective alternative to traditional antibody-based methods for validating toxicity biomarkers. This protein quantification technique accelerates biomarker discovery by overcoming traditional bottlenecks.
Area of Science:
- Toxicology and Omics Technologies
- Biomarker Discovery and Validation
Background:
- The rapid advancement of -omics technologies has led to an exponential increase in toxicological data generation.
- Discovering novel toxicity biomarkers is outpacing traditional validation methods, creating a significant bottleneck.
- Conventional validation relies on antibody-based techniques (Western blotting, ELISA, immunohistochemistry), which are time-consuming and costly.
Purpose of the Study:
- To explore the utility of triple quadrupole (QQQ) mass spectrometry (MS) as an alternative platform for protein quantification.
- To address the limitations of antibody-dependent validation methods in toxicology.
- To present QQQ-MS as a strategy for efficient and accessible biomarker validation.
Main Methods:
- Utilized triple quadrupole (QQQ) mass spectrometry (MS) for targeted protein quantification.
- Developed assays for protein targets without the need for antibody development.
- Leveraged the multiplexing capabilities of QQQ-MS for parallel analysis.
Main Results:
- QQQ-MS provides a viable alternative to antibody-based validation techniques.
- Assay development for QQQ-MS is generally less expensive and faster than antibody generation.
- The technique allows for accessible multiplexing, enhancing throughput.
Conclusions:
- Triple quadrupole mass spectrometry (QQQ-MS) offers a rapid, flexible, and cost-effective approach for validating toxicity biomarkers.
- This method overcomes the bottlenecks associated with traditional antibody-based validation.
- QQQ-MS represents a valuable strategy for accelerating the validation of newly discovered biomarkers in toxicology.
Related Concept Videos
01:21Tandem Mass Spectrometry
01:19Mass Spectrometry: Overview
01:21Mass Spectrometry: Complex Analysis
GC–MS is a powerful hyphenated method commonly used in forensics and environmental...
01:33Peptide Identification Using Tandem Mass Spectrometry
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
01:19MALDI-TOF Mass Spectrometry